269 related articles for article (PubMed ID: 24116744)
21. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
[TBL] [Abstract][Full Text] [Related]
22. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
25. Contribution of Peptide Backbone to Anti-Citrullinated Peptide Antibody Reactivity.
Trier NH; Dam CE; Olsen DT; Hansen PR; Houen G
PLoS One; 2015; 10(12):e0144707. PubMed ID: 26657009
[TBL] [Abstract][Full Text] [Related]
26. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
27. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.
Ossipova E; Cerqueira CF; Reed E; Kharlamova N; Israelsson L; Holmdahl R; Nandakumar KS; Engström M; Harre U; Schett G; Catrina AI; Malmström V; Sommarin Y; Klareskog L; Jakobsson PJ; Lundberg K
Arthritis Res Ther; 2014 Aug; 16(4):R167. PubMed ID: 25112157
[TBL] [Abstract][Full Text] [Related]
28. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues.
Girbal-Neuhauser E; Durieux JJ; Arnaud M; Dalbon P; Sebbag M; Vincent C; Simon M; Senshu T; Masson-Bessière C; Jolivet-Reynaud C; Jolivet M; Serre G
J Immunol; 1999 Jan; 162(1):585-94. PubMed ID: 9886436
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
30. The use of citrullinated peptides for the diagnosis and prognosis of rheumatoid arthritis.
Haro I; Gómara MJ
Curr Top Med Chem; 2014; 14(23):2729-33. PubMed ID: 25515746
[TBL] [Abstract][Full Text] [Related]
31. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis.
Brink M; Hansson M; Mathsson L; Jakobsson PJ; Holmdahl R; Hallmans G; Stenlund H; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
Arthritis Rheum; 2013 Apr; 65(4):899-910. PubMed ID: 23310951
[TBL] [Abstract][Full Text] [Related]
32. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.
Coenen D; Verschueren P; Westhovens R; Bossuyt X
Clin Chem; 2007 Mar; 53(3):498-504. PubMed ID: 17259232
[TBL] [Abstract][Full Text] [Related]
33. Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?
Szekanecz Z; Soós L; Szabó Z; Fekete A; Kapitány A; Végvári A; Sipka S; Szücs G; Szántó S; Lakos G
Clin Rev Allergy Immunol; 2008 Feb; 34(1):26-31. PubMed ID: 18270854
[TBL] [Abstract][Full Text] [Related]
34. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation.
Ytterberg AJ; Joshua V; Reynisdottir G; Tarasova NK; Rutishauser D; Ossipova E; Haj Hensvold A; Eklund A; Sköld CM; Grunewald J; Malmström V; Jakobsson PJ; Rönnelid J; Padyukov L; Zubarev RA; Klareskog L; Catrina AI
Ann Rheum Dis; 2015 Sep; 74(9):1772-7. PubMed ID: 24817415
[TBL] [Abstract][Full Text] [Related]
35. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.
Burkhardt H; Sehnert B; Bockermann R; Engström A; Kalden JR; Holmdahl R
Eur J Immunol; 2005 May; 35(5):1643-52. PubMed ID: 15832289
[TBL] [Abstract][Full Text] [Related]
36. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.
Lundberg K; Bengtsson C; Kharlamova N; Reed E; Jiang X; Kallberg H; Pollak-Dorocic I; Israelsson L; Kessel C; Padyukov L; Holmdahl R; Alfredsson L; Klareskog L
Ann Rheum Dis; 2013 May; 72(5):652-8. PubMed ID: 22661643
[TBL] [Abstract][Full Text] [Related]
37. Weak CD4+ T-cell responses to citrullinated vimentin in rheumatoid arthritis patients carrying HLA-DR9 alleles.
Catalán D; Aravena O; Zúñiga R; Silva N; Escobar A; Sabugo F; Wurmann P; Soto L; González R; Alfaro J; Larrondo M; Cuchacovich M; Aguillón JC
Rheumatol Int; 2012 Jun; 32(6):1819-25. PubMed ID: 21769486
[TBL] [Abstract][Full Text] [Related]
38. Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.
Zheng Z; Mergaert AM; Fahmy LM; Bawadekar M; Holmes CL; Ong IM; Bridges AJ; Newton MA; Shelef MA
Arthritis Rheumatol; 2020 Feb; 72(2):262-272. PubMed ID: 31397047
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies.
Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2016 May; 18(1):96. PubMed ID: 27145822
[TBL] [Abstract][Full Text] [Related]
40. Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission.
Pelzek AJ; Grönwall C; Rosenthal P; Greenberg JD; McGeachy M; Moreland L; Rigby WFC; Silverman GJ
Arthritis Rheumatol; 2017 Jun; 69(6):1176-1186. PubMed ID: 28118534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
